{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:08:58Z","timestamp":1763507338163,"version":"3.45.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Science and Technology Research","award":["252102310525","252102310525"],"award-info":[{"award-number":["252102310525","252102310525"]}]},{"name":"Key Research Projects of Higher Education Institutions in Henan Province","award":["25A360001"],"award-info":[{"award-number":["25A360001"]}]},{"name":"National Research Project Cultivation Fund of Huanghuai University in 2024","award":["No. XKPY-2024012"],"award-info":[{"award-number":["No. XKPY-2024012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01858-1","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:51:18Z","timestamp":1763463078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role and interaction of LncRNAs and insulin resistance in polycystic ovary syndrome: a narrative review"],"prefix":"10.1186","volume":"18","author":[{"given":"Mengfan","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baosong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"1858_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mcna.2022.10.004","volume":"107","author":"S Shrivastava","year":"2023","unstructured":"Shrivastava S, Conigliaro RL. Polycystic ovarian syndrome. Med Clin North Am. 2023;107:227\u201334. https:\/\/doi.org\/10.1016\/j.mcna.2022.10.004.","journal-title":"Med Clin North Am"},{"key":"1858_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01552-8","volume":"17","author":"X Xin","year":"2024","unstructured":"Xin X, Dong L, Li J, Chen W, Qiu Y, Lian F, et al. Exploring lncRNA expression in follicular fluid exosomes of patients with obesity and polycystic ovary syndrome based on high-throughput sequencing technology. J Ovarian Res. 2024;17:220. https:\/\/doi.org\/10.1186\/s13048-024-01552-8.","journal-title":"J Ovarian Res"},{"key":"1858_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3969\/j.issn.2095-8803.2024.01.008","volume":"11","author":"LR Guo","year":"2024","unstructured":"Guo LR, Huang XY, Guo JF, Li LZ, Lin RF, Chen GY. The value of TLR4 signaling pathway in predicting polycystic ovary syndrome with unexplained recurrent miscarriage. Electron J Practical Gynecol Endocrinol. 2024;11:26\u20138. https:\/\/doi.org\/10.3969\/j.issn.2095-8803.2024.01.008.","journal-title":"Electron J Practical Gynecol Endocrinol"},{"key":"1858_CR4","first-page":"1281","volume":"38","author":"ZM Pan","year":"2023","unstructured":"Pan ZM, Sun M, Xu F, Hou LH, Kuang HY. Clinical characteristics analysis of phlegm-dampness syndrome polycystic ovary syndrome with prediabetes. China J Tradit Chin Med Pharm. 2023;38:1281\u20136.","journal-title":"China J Tradit Chin Med Pharm"},{"key":"1858_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002953","volume":"16","author":"NYH Ng","year":"2019","unstructured":"Ng NYH, Jiang G, Cheung LP, Zhang Y, Tam CHT, Luk AOY, et al. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: a case-control study. PLoS Med. 2019;16:e1002953. https:\/\/doi.org\/10.1371\/journal.pmed.1002953.","journal-title":"PLoS Med"},{"key":"1858_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3969\/j.issn.2097-115X.2025.06.040","volume":"4","author":"TY Zhu","year":"2025","unstructured":"Zhu TY, Liu Y, Cao J. Analysis of clinical characteristics of different body mass index in patients with polycystic ovary syndrome. J Women Children\u2019s Health Guide. 2025;4:182\u20137. https:\/\/doi.org\/10.3969\/j.issn.2097-115X.2025.06.040.","journal-title":"J Women Children\u2019s Health Guide"},{"key":"1858_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jwh.2014.5000","volume":"24","author":"AE Joham","year":"2015","unstructured":"Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health. 2015;24:299\u2013307. https:\/\/doi.org\/10.1089\/jwh.2014.5000.","journal-title":"J Womens Health"},{"issue":"1","key":"1858_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49749-1","volume":"15","author":"M Bahri Khomami","year":"2024","unstructured":"Bahri Khomami M, Shorakae S, Hashemi S, Harrison CL, Piltonen TT, Romualdi D, et al. Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Nat Commun. 2024;15(1):5591. https:\/\/doi.org\/10.1038\/s41467-024-49749-1.","journal-title":"Nat Commun"},{"key":"1858_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.13241\/j.cnki.pmb.2025.03.022","volume":"25","author":"L Liu","year":"2025","unstructured":"Liu L, Shen Q, Liu ZH. Relationship between serum AMH, D-D, HMGB-1 levels and early threatened abortion in PCOS patients. Progress Mod Biomed. 2025;25:566\u201374. https:\/\/doi.org\/10.13241\/j.cnki.pmb.2025.03.022.","journal-title":"Progress Mod Biomed"},{"key":"1858_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.fertnstert.2017.12.023","volume":"109","author":"Y Li","year":"2018","unstructured":"Li Y, Ruan X, Wang H, et al. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment. Fertil Steril. 2018;109:720\u20137. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.12.023.","journal-title":"Fertil Steril"},{"key":"1858_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.fertnstert.2020.09.169","volume":"115","author":"SL Robinson","year":"2021","unstructured":"Robinson SL, Yeung EH. Polycystic ovary syndrome and preterm birth-what\u2019s going on? Fertil Steril. 2021;115:326\u20137. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.09.169.","journal-title":"Fertil Steril"},{"key":"1858_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","volume":"21","author":"S Palomba","year":"2015","unstructured":"Palomba S, de Wilde MA, Falbo A, et al. Pregnancy complications in women with polycystic ovary SyndromeJ. Hum Reprod Update. 2015;21:575\u201392. https:\/\/doi.org\/10.1093\/humupd\/dmv029.","journal-title":"Hum Reprod Update"},{"key":"1858_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3969\/j.issn.1672-1993.2022.06.025","volume":"31","author":"LJ Cai","year":"2022","unstructured":"Cai LJ, HAn HM, PAng TL, Wu CL. Study on the correlation between abdominal visceral fat and the risk of endometrial cancer in patients with polycystic ovary syndrome. Chin J Hum Sexuality. 2022;31:95\u20139. https:\/\/doi.org\/10.3969\/j.issn.1672-1993.2022.06.025.","journal-title":"Chin J Hum Sexuality"},{"key":"1858_CR14","first-page":"954","volume":"33","author":"DD Ma","year":"2022","unstructured":"Ma DD, Zhou YF. Risk factors of endometrial cancer in patients with polycystic ovarian syndrome in child-bearing age. Mod Diagn Treat. 2022;33:954\u20136.","journal-title":"Mod Diagn Treat"},{"key":"1858_CR15","doi-asserted-by":"publisher","unstructured":"Wang MJ. Exploring the correlation and potential mechanisms between polycystic ovary syndrome and the risk of ovarian cancer based on transcriptomics dissertation\/master\u2019s thesis. Hunan: Nanhua University. 2023. https:\/\/doi.org\/10.27234\/d.cnki.gnhuu.2023.000759.","DOI":"10.27234\/d.cnki.gnhuu.2023.000759"},{"key":"1858_CR16","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.20043\/j.cnki.MPM.202212432","volume":"50","author":"YX Xu","year":"2023","unstructured":"Xu YX, Li HQ, Qin ZQ. Mendelian randomization analysis of the causal relationship between polycystic ovary syndrome and female malignant tumors. Mod Prev Med. 2023;50:4253\u20139. https:\/\/doi.org\/10.20043\/j.cnki.MPM.202212432.","journal-title":"Mod Prev Med"},{"key":"1858_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.12280\/gjfckx.20241018","volume":"52","author":"HB Yan","year":"2025","unstructured":"Yan HB, Zhang L. Analysis of the disease burden and projections of polycystic ovary syndrome in China and globally from 1990 to 2021. J Int Obstet Gynecol. 2025;52:228\u201333. https:\/\/doi.org\/10.12280\/gjfckx.20241018.","journal-title":"J Int Obstet Gynecol"},{"key":"1858_CR18","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ncrna.2024.05.003","volume":"9","author":"X Lin","year":"2024","unstructured":"Lin X, Nie X, Deng P, Wang L, Hu C, Jin N. Whispers of the polycystic ovary syndrome theater: directing role of long noncoding RNAs. Non-coding RNA Res. 2024;9:1023\u201332. https:\/\/doi.org\/10.1016\/j.ncrna.2024.05.003.","journal-title":"Non-coding RNA Res"},{"key":"1858_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3760\/cma.j.cn101441-20240829-00320","volume":"45","author":"BS Liu","year":"2025","unstructured":"Liu BS, Li CX, Sun YY, Zhang XF, Peng MF. Dual regulatory mechanism and clinical value of LncRNA in polycystic ovary syndrome, and current research status of traditional Chinese medicine intervention. Chin J Reprod Contracept. 2025;45:77\u201384. https:\/\/doi.org\/10.3760\/cma.j.cn101441-20240829-00320.","journal-title":"Chin J Reprod Contracept"},{"key":"1858_CR20","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.13404\/j.cnki.cjbhh.2022.08.029","volume":"30","author":"XY Yu","year":"2022","unstructured":"Yu XY, Yang HL, Wang LH. Influence of LncRNA ZFAS1 on insulin resistance in Mice with polycystic ovary syndrome by regulating Mi R-136-5p\/IGF1R axis. Chin J Birth Health Heredity. 2022;30:1365\u201370. https:\/\/doi.org\/10.13404\/j.cnki.cjbhh.2022.08.029.","journal-title":"Chin J Birth Health Heredity"},{"key":"1858_CR21","unstructured":"Song HX. Mechanism study of LncRNA MEG3 in insulin resistance of polycystic ovary syndrome dissertation\/master\u2019s thesis. Shandong: Shandong University. 2022."},{"key":"1858_CR22","doi-asserted-by":"publisher","unstructured":"Na ZJ. Mechanism of LncRNA RP11-705C15.3 regulating ovarian granulocyte autophagy in polycystic ovary syndrome via miR-34c-5p\/IGF2 Axis dissertation\/ master\u2019s thesis. Beijing: China Medical University. 2022. https:\/\/doi.org\/10.27652\/d.cnki.gzyku.2022.000210.","DOI":"10.27652\/d.cnki.gzyku.2022.000210"},{"key":"1858_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000513671","volume":"86","author":"Y Qi","year":"2021","unstructured":"Qi Y, Yin Q, Gu J, Liu Y, Sun Q, Cao Y, et al. Elevated circulating levels of carnal ENST00000550337.1 are associated with polycystic ovary syndrome in Chinese women. Gynecol Obstet Invest. 2021;86:155\u201361. https:\/\/doi.org\/10.1159\/000513671.","journal-title":"Gynecol Obstet Invest"},{"key":"1858_CR24","doi-asserted-by":"publisher","first-page":"102531","DOI":"10.1016\/j.tice.2024","volume":"91","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang J. BRD4 absence inactivates Endoplasmic reticulum stress to retard dehydroepiandrosterone-triggered ovarian granular cell apoptosis in polycystic ovary syndrome via GRP78. Tissue Cell. 2024;91:102531. https:\/\/doi.org\/10.1016\/j.tice.2024.","journal-title":"Tissue Cell"},{"key":"1858_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.648701","volume":"12","author":"R Zhao","year":"2021","unstructured":"Zhao R, Jiang Y, Zhao S, Zhao H. Multiomics analysis reveals molecular abnormalities in granulosa cells of women with polycystic ovary syndrome. Front Genet. 2021;12:648701. https:\/\/doi.org\/10.3389\/fgene.2021.648701.","journal-title":"Front Genet"},{"key":"1858_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.rbmo.2022.01.007","volume":"44","author":"W Zhou","year":"2022","unstructured":"Zhou W, Zhang T, Lian Y, Zhang W, Yang M, Li Y, et al. Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks. Reprod Biomed Online. 2022;44:777\u201390. https:\/\/doi.org\/10.1016\/j.rbmo.2022.01.007.","journal-title":"Reprod Biomed Online"},{"key":"1858_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-01806-w","volume":"17","author":"X Xu","year":"2024","unstructured":"Xu X, Yang A, Tian P, Zhang K, Liu Y, Wang Y, et al. Expression profile analysis of LncRNAs and mRNAs in pre-receptive endometrium of women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer. BMC Med Genomics. 2024;17:26. https:\/\/doi.org\/10.1186\/s12920-024-01806-w.","journal-title":"BMC Med Genomics"},{"key":"1858_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00718-z","volume":"19","author":"H Gao","year":"2021","unstructured":"Gao H, Jiang J, Shi Y, Chen J, Zhao L, Wang C. The LINC00477\/miR-128 axis promotes the progression of polycystic ovary syndrome by regulating ovarian granulosa cell proliferation and apoptosis. Reprod Biol Endocrinol. 2021;19:29. https:\/\/doi.org\/10.1186\/s12958-021-00718-z.","journal-title":"Reprod Biol Endocrinol"},{"key":"1858_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3969\/j.issn.1000-4718.2025","volume":"41","author":"YL Lu","year":"2025","unstructured":"Lu YL, Pang XX, Chen XH, Wei YX, Liu CH. Correlation between genetic polymorphism of LncRNA GAS5 and risk of polycystic ovary syndromem. Chin J Pathophysiology. 2025;41:348\u201353. https:\/\/doi.org\/10.3969\/j.issn.1000-4718.2025.","journal-title":"Chin J Pathophysiology"},{"key":"1858_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01571-5","volume":"17","author":"L Qin","year":"2024","unstructured":"Qin L, Tian C, Huang L, Qin X, Ling S, Wei J, et al. Clinical significance and biological roles of LncRNA CTBP1-AS in polycystic ovary syndrome. J Ovarian Res. 2024;17:248. https:\/\/doi.org\/10.1186\/s13048-024-01571-5.","journal-title":"J Ovarian Res"},{"key":"1858_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/09513590.2014.999763","volume":"31","author":"Z Liu","year":"2015","unstructured":"Liu Z, Hao C, Huang X, Zhang N, Bao H, Qu Q. Peripheral blood leukocyte expression level of LncRNA steroid receptor RNA activator (SRA;and its association with polycystic ovary syndrome: a case control study. Gynecol Endocrinol. 2015;31:363\u20138. https:\/\/doi.org\/10.3109\/09513590.2014.999763.","journal-title":"Gynecol Endocrinol"},{"key":"1858_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.19664\/j.cnki.1002-2392.230196","volume":"51","author":"F Xu","year":"2023","unstructured":"Xu F, Liang JL, Pan ZM, Sun M, Ma M. Expressions of LncRNA SRA and sphingomyelin in PCOS patients with kidney deficiency and liver depression and their diagnostic significance. Acta Chin Med Pharmacol. 2023;51:72\u20137. https:\/\/doi.org\/10.19664\/j.cnki.1002-2392.230196.","journal-title":"Acta Chin Med Pharmacol"},{"key":"1858_CR33","doi-asserted-by":"publisher","unstructured":"Cai FY. Study on the co expression profile of lncRNA mRNA in peripheral blood of patients with polycystic ovary syndrome of phlegm dampness type and non phlegm dampness type dissertation\/master\u2019s thesis. Guangzhou: Guangzhou University of Traditional Chinese Medicine. 2024. https:\/\/doi.org\/10.27044\/d.cnki.ggzzu.2024.000760 .","DOI":"10.27044\/d.cnki.ggzzu.2024"},{"issue":"1","key":"1858_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/jcmm.14753","volume":"24","author":"B Jiang","year":"2020","unstructured":"Jiang B, Xue M, Xu D, Song J, Zhu S. Down-regulated LncRNA HOTAIR alleviates polycystic ovaries syndrome in rats by reducing expression of insulin-like growth factor 1 via microRNA-130a. J Cell Mol Med. 2020;24(1):451\u201364. https:\/\/doi.org\/10.1111\/jcmm.14753.","journal-title":"J Cell Mol Med"},{"key":"1858_CR35","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ymthe.2020.11.018","volume":"29","author":"X Geng","year":"2021","unstructured":"Geng X, Zhao J, Huang J, Li S, Chu W, Wang WS. Lnc-MAP3K13-7:1 inhibits ovarian GC proliferation in PCOS via DNMT1 downregulation-mediated CDKN1A promoter hypomethylation. Mol Ther. 2021;29:1279\u201393. https:\/\/doi.org\/10.1016\/j.ymthe.2020.11.018.","journal-title":"Mol Ther"},{"key":"1858_CR36","doi-asserted-by":"publisher","first-page":"108522","DOI":"10.1016\/j.isci.2023.108522","volume":"27","author":"Z Yang","year":"2023","unstructured":"Yang Z, Pan J, Zhou C, Yu C, Zhou Z, Ding G, et al. LncRNA SNHG5 adversely governs follicular growth in PCOS via miR-92a-3p\/CDKN1C axis. iScience. 2023;27:108522. https:\/\/doi.org\/10.1016\/j.isci.2023.108522.","journal-title":"iScience"},{"key":"1858_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110589","volume":"499","author":"D Zhang","year":"2020","unstructured":"Zhang D, Tang HY, Tan L, Zhao DM. MALAT1 is involved in the pathophysiological process of PCOS by modulating TGF\u03b2 signaling in granulosa cells. Mol Cell Endocrinol. 2020;499:110589. https:\/\/doi.org\/10.1016\/j.mce.2019.110589.","journal-title":"Mol Cell Endocrinol"},{"key":"1858_CR38","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20209266","volume":"53","author":"X Sun","year":"2020","unstructured":"Sun X, Yan X, Liu K, Wu M, Li Z, Wang Y, et al. LncRNA H19 acts as a CeRNA to regulate the expression of CTGF by targeting miR-19b in polycystic ovary syndrome. Braz J Med Biol Res. 2020;53:e9266. https:\/\/doi.org\/10.1590\/1414-431X20209266.","journal-title":"Braz J Med Biol Res"},{"key":"1858_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.rbmo.2018.08.005","volume":"37","author":"L Jin","year":"2018","unstructured":"Jin L, Yang Q, Zhou C, Liu L, Wang H, Hou M, et al. Profiles for long non-coding RNAs in ovarian granulosa cells from women with PCOS with or without hyperandrogenism. Reprod Biomed Online. 2018;37:613\u201323. https:\/\/doi.org\/10.1016\/j.rbmo.2018.08.005.","journal-title":"Reprod Biomed Online"},{"key":"1858_CR40","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.omtn.2020.12.008","volume":"23","author":"J Huang","year":"2020","unstructured":"Huang J, Zhao J, Geng X, Chu W, Li S, Chen ZJ, et al. Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome. Mol Ther Nucleic Acids. 2020;23:614\u201328. https:\/\/doi.org\/10.1016\/j.omtn.2020.12.008.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1858_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ncrna.2023.02.008","volume":"8","author":"AA ElMonier","year":"2023","unstructured":"ElMonier AA, El-Boghdady NA, Fahim SA, Sabry D, Elsetohy KA, Shaheen AA. LncRNA NEAT1 and MALAT1 are involved in polycystic ovary syndrome pathogenesis by functioning as competing endogenous RNAs to control the expression of PCOS-related target genes. Noncoding RNA Res. 2023;8:263\u201371. https:\/\/doi.org\/10.1016\/j.ncrna.2023.02.008.","journal-title":"Noncoding RNA Res"},{"key":"1858_CR42","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10815-024-03092-y","volume":"41","author":"L Yu","year":"2024","unstructured":"Yu L, Wang C, Liu M, Xia L, Liu T, Che Q, et al. Follicular fluid-derived exosomal LncRNA LIPE-AS1 modulates steroid metabolism and survival of granulosa cells leading to oocyte maturation arrest in polycystic ovary syndrome. J Assist Reprod Genet. 2024;41:1387\u2013401. https:\/\/doi.org\/10.1007\/s10815-024-03092-y.","journal-title":"J Assist Reprod Genet"},{"key":"1858_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2023.100764","volume":"23","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Zhang X, Yi G, Zhang Y, Zhang J, Tan C, et al. LINC00092 derived from follicular fluid alleviated the symptoms of PCOS through inactivation of phosphatase and tensin homolog by recruiting KDM5A. Reprod Biol. 2023;23:100764. https:\/\/doi.org\/10.1016\/j.repbio.2023.100764.","journal-title":"Reprod Biol"},{"key":"1858_CR44","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1007\/s43032-023-01251-7","volume":"30","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Zhang Y, Zhang X, Zhang J, Yi G, Wan B, et al. Follicular fluid-derived small extracellular vesicles alleviate DHEA-induced granulosa cell apoptosis by delivering LINC00092. Reprod Sci. 2023;30:3092\u2013102. https:\/\/doi.org\/10.1007\/s43032-023-01251-7.","journal-title":"Reprod Sci"},{"key":"1858_CR45","doi-asserted-by":"publisher","unstructured":"Xin X. Exploring the mechanism of electroacupuncture in improving oocyte quality in patients with phlegm dampness polycystic ovary syndrome based on sequencing of lncRNA from follicular fluid exosomes dissertation\/master\u2019s thesis. Shandong: Shandong University of Traditional Chinese Medicine. 2023. https:\/\/doi.org\/10.27282\/d.cnki.gsdzu.2023.000491","DOI":"10.27282\/d.cnki.gsdzu.2023.000491"},{"key":"1858_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03592-z","author":"G Eriksson","year":"2025","unstructured":"Eriksson G, Li C, Sparovec TG, Dekanski A, Torstensson S, Risal S, et al. Single-cell profiling of the human endometrium in polycystic ovary syndrome. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03592-z.","journal-title":"Nat Med"},{"key":"1858_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-018-0412-4","volume":"16","author":"X Zhang","year":"2018","unstructured":"Zhang X, Xu Y, Fu L, Li D, Dai X, Liu L, et al. Identification of mRNAs related to endometrium function regulated by LncRNA CD36-005 in rat endometrial stromal cells. Reprod Biol Endocrinol. 2018;16:96. https:\/\/doi.org\/10.1186\/s12958-018-0412-4.","journal-title":"Reprod Biol Endocrinol"},{"key":"1858_CR48","doi-asserted-by":"publisher","unstructured":"Jiang YN. Study on mRNA, lncRNA, and miRNA expression profiles in the endometrium of polycystic ovary syndrome mice during the receptive period dissertation\/master\u2019s thesis. Henan:. Zhengzhou University 2021. https:\/\/doi.org\/10.27466\/d.cnki.gzzdu.2021.002646","DOI":"10.27466\/d.cnki.gzzdu.2021.002646"},{"key":"1858_CR49","unstructured":"Zhang XY. Research on identification of IncRNA CD36-005 expression in the uteri of PCOS rat model and related functions dissertation\/master\u2019s thesis. Jilin: Jilin University. 2019."},{"key":"1858_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of lterature. J Healthc Eng. 2022;2022:9240569. https:\/\/doi.org\/10.1155\/2022\/9240569.","journal-title":"J Healthc Eng"},{"key":"1858_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16:9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0.","journal-title":"J Ovarian Res"},{"key":"1858_CR52","doi-asserted-by":"publisher","first-page":"e2300915","DOI":"10.1002\/mnfr.202300915","volume":"68","author":"R Hu","year":"2024","unstructured":"Hu R, Long S, Luo M, Tang B, Tan T, Dong W, et al. Hyperglycemia inhibits hepatic SHBG synthesis through the NGBR-AMPK-HNF4 pathway in rats with polycystic ovary syndrome induced by letrozole in combination with a High-Fat diet. Mol Nutr Food Res. 2024;68:e2300915. https:\/\/doi.org\/10.1002\/mnfr.202300915.","journal-title":"Mol Nutr Food Res"},{"key":"1858_CR53","doi-asserted-by":"publisher","unstructured":"Bo XL, PAn J, Zhu AL, He BY, Haliya HLMBK. Correlations of HOMA-IR, T and SHBG levels in patients with polycystic ovary syndrome. J Mol Diagnost Ther. 2021;13:1369\u20131371\u2009+\u20091376. https:\/\/doi.org\/10.19930\/j.cnki.jmdt 2021.08.042.","DOI":"10.19930\/j.cnki.jmdt"},{"key":"1858_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113947","volume":"273","author":"MF Peng","year":"2021","unstructured":"Peng MF, Tian S, Song YG, Li CX, Miao MS, Ren Z. Effects of total flavonoids from eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet. J Ethnopharmacol. 2021;273:113947. https:\/\/doi.org\/10.1016\/j.jep.2021.113947.","journal-title":"J Ethnopharmacol"},{"key":"1858_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1457467","volume":"15","author":"Z Yong","year":"2024","unstructured":"Yong Z, Mimi C, Yingjie L, Yichen G, Yansu Y, Zhi Z, et al. Mangiferin ameliorates polycystic ovary syndrome in rats by modulating insulin resistance, gut microbiota, and ovarian cell apoptosis. Front Pharmacol. 2024;15:1457467. https:\/\/doi.org\/10.3389\/fphar.2024.1457467.","journal-title":"Front Pharmacol"},{"key":"1858_CR56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3969\/j.issn.1672-0369.2024.23.039","volume":"36","author":"LP Ma","year":"2024","unstructured":"Ma LP, Lv WX. Correlations between serum follicle stimulating hormone, luteinizing hormone,prolactin levels and insulin resistance in patients with polycystic ovary syndrome. Med J Chin People\u2019s Health. 2024;36:125\u20137. https:\/\/doi.org\/10.3969\/j.issn.1672-0369.2024.23.039.","journal-title":"Med J Chin People\u2019s Health"},{"key":"1858_CR57","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.14035\/j.cnki.hljyy.2024.06.013","volume":"37","author":"YZ Xiong","year":"2024","unstructured":"Xiong YZ, Deng SL. Correlation of serum anti-mullerian hormone with insulin resistance and free testosterone index in women with polycystic ovary syndrome of childbearing age. Heilongjiang Med J. 2024;37:1281\u20134. https:\/\/doi.org\/10.14035\/j.cnki.hljyy.2024.06.013.","journal-title":"Heilongjiang Med J"},{"key":"1858_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11120869","volume":"11","author":"W Chen","year":"2021","unstructured":"Chen W, Pang Y. Metabolic syndrome and PCOS: pathogenesis and the role of metabolites. Metabolites. 2021;11:869. https:\/\/doi.org\/10.3390\/metabo11120869.","journal-title":"Metabolites"},{"key":"1858_CR59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.16068\/j.1000-1824.2025.01.006","volume":"48","author":"CQ Li","year":"2025","unstructured":"Li CQ. Correlation analysis of abdominal obesity, hyperandrogenemia, insulin resistance and lipid metabolism in patients with polycystic ovary syndrome. J Med Sci Yanbian Univ. 2025;48:18\u201320. https:\/\/doi.org\/10.16068\/j.1000-1824.2025.01.006.","journal-title":"J Med Sci Yanbian Univ"},{"key":"1858_CR60","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3969\/j.issn.1004-3845.2024","volume":"33","author":"HF Jia","year":"2024","unstructured":"Jia HF, Zhen JH, Hao XY. Construction and validation of a risk prediction model for metabolic syndrome in patients with polycystic ovary syndrome. J Reprod Med. 2024;33:1183\u201391. https:\/\/doi.org\/10.3969\/j.issn.1004-3845.2024. 09.009.","journal-title":"J Reprod Med"},{"key":"1858_CR61","unstructured":"Tan JT, Qian HQ, Tang YY, Zai PL, Wang YT, Zhang JJ. Prognostic factors and prediction model construction in patients with polycystic ovary syndrome. J Chengdu Med Coll. 2025:1\u201311. doi:10.3969\/j.issn.1674-2257.2025.05.008."},{"key":"1858_CR62","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.19829\/j.zgfybj.issn.1001-4411.2024.21.027","volume":"39","author":"Y Lv","year":"2024","unstructured":"Lv Y, Liu HY, Hu FH, Wu HL, Zhang GL. The expression of FOXO1 and MCL1 in patients with polycystic ovary syndrome and their relationship with glucose and lipid metabolism and insulin resistance. Maternal Child Health Care China. 2024;39:4243\u20136. https:\/\/doi.org\/10.19829\/j.zgfybj.issn.1001-4411.2024.21.027.","journal-title":"Maternal Child Health Care China"},{"key":"1858_CR63","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3969\/j.issn.1674-4985.2024.34.023","volume":"21","author":"L Chen","year":"2024","unstructured":"Chen L, Li JN. Association between inflammatory markers and metabolic disorders in women of reproductive age with polycystic ovary syndrome. Med Innov China. 2024;21:97\u2013101. https:\/\/doi.org\/10.3969\/j.issn.1674-4985.2024.34.023.","journal-title":"Med Innov China"},{"key":"1858_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145888","volume":"807","author":"D Wang","year":"2022","unstructured":"Wang D, Wang H, Li M, Zhao R. Chemerin levels and its genetic variants are associated with gestational diabetes mellitus: a hospital-based study in a Chinese cohort. Gene. 2022;807:145888. https:\/\/doi.org\/10.1016\/j.gene.2021.145888.","journal-title":"Gene"},{"key":"1858_CR65","doi-asserted-by":"publisher","first-page":"385","DOI":"10.16343\/j.cnki.issn.2095-512x.2024.04.006","volume":"46","author":"WH Zhao","year":"2024","unstructured":"Zhao WH, Sun WF, Ma YZ, Zhu SF, He JY. Correlation analysis between serum chemerin levels and endocrine and metabolic indicators in patients with polycystic ovary syndrome. J Inner Mongolia Med Univ. 2024;46:385\u20139. https:\/\/doi.org\/10.16343\/j.cnki.issn.2095-512x.2024.04.006.","journal-title":"J Inner Mongolia Med Univ"},{"key":"1858_CR66","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.19829\/j.zgfybj.issn.1001-4411.2024.23.019","volume":"39","author":"MM Chen","year":"2024","unstructured":"Chen MM, Lin C, Zhang H. Correlation analysis between insulin resistance index and Th1\/Th2 balance changes in infertile patients with polycystic ovary syndrome. Maternal Child Health Care China. 2024;39:4661\u20134. https:\/\/doi.org\/10.19829\/j.zgfybj.issn.1001-4411.2024.23.019.","journal-title":"Maternal Child Health Care China"},{"key":"1858_CR67","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11886-024-02050-5","volume":"26","author":"P Dubey","year":"2024","unstructured":"Dubey P, Reddy S, Sharma K, Johnson S, Hardy G, Dwivedi AK. Polycystic ovary syndrome, insulin resistance, and cardiovascular disease. Curr Cardiol Rep. 2024;26:483\u201395. https:\/\/doi.org\/10.1007\/s11886-024-02050-5.","journal-title":"Curr Cardiol Rep"},{"key":"1858_CR68","doi-asserted-by":"publisher","first-page":"76","DOI":"10.13194\/j.issn.1673-842X","volume":"27","author":"YN He","year":"2025","unstructured":"He YN, Wang HN, Lin HN, Li L, Liu D, Lin CL. Analysis of infrared characteristics in patients with polycystic ovary syndrome accompanied by insulin resistance. J Liaoning Univ Traditional Chin Med. 2025;27:76\u201381. https:\/\/doi.org\/10.13194\/j.issn.1673-842X. 2025.06.016.","journal-title":"J Liaoning Univ Traditional Chin Med"},{"key":"1858_CR69","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3969\/j.issn.1674-3806.2024.08.12","volume":"17","author":"JM Lei","year":"2024","unstructured":"Lei JM, Feng YH, Zhang O, Gao S, Chen W. A study on the correlation of serum levels of lncRNA-XIST and lncRNA-MALAT1 with insulin resistance and pregnancy outcome after ovulation induction therapy in infertile patients with polycystic ovary syndrome. Chin J New Clin Med. 2024;17:901\u20136. https:\/\/doi.org\/10.3969\/j.issn.1674-3806.2024.08.12.","journal-title":"Chin J New Clin Med"},{"issue":"1","key":"1858_CR70","doi-asserted-by":"publisher","first-page":"e3907","DOI":"10.1002\/cbf.3907","volume":"42","author":"EA Adu-Gyamfi","year":"2024","unstructured":"Adu-Gyamfi EA, Cheeran EA, Salamah J, Lee BK. Long noncoding RNA H19 in ovarian biology and placenta development. Cell Biochem Funct. 2024;42(1):e3907. https:\/\/doi.org\/10.1002\/cbf.3907.","journal-title":"Cell Biochem Funct"},{"key":"1858_CR71","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s43032-021-00700-5","volume":"29","author":"Z Chen","year":"2022","unstructured":"Chen Z, Liu L, Xi X, Burn M, Karakaya C, Kallen AN. Aberrant H19 expression disrupts ovarian Cyp17 and testosterone production and is associated with polycystic ovary syndrome in women. Reprod Sci. 2022;29:1357\u201367. https:\/\/doi.org\/10.1007\/s43032-021-00700-5.","journal-title":"Reprod Sci"},{"key":"1858_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-019-0239-2","volume":"52","author":"C Cui","year":"2019","unstructured":"Cui C, Li Z, Wu D. The long non-coding RNA H19 induces hypoxia\/ reoxygenation injury by up-regulating autophagy in the hepatoma carcinoma cells. Biol Res. 2019;52:32. https:\/\/doi.org\/10.1186\/s40659-019-0239-2.","journal-title":"Biol Res"},{"key":"1858_CR73","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s40618-023-02119-y","volume":"46","author":"P Moghetti","year":"2023","unstructured":"Moghetti P, Catellani C, Sartori C, Migazzi M, Cirillo F, Villani M, et al. Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS. J Endocrinol Invest. 2023;46:2629\u201337. https:\/\/doi.org\/10.1007\/s40618-023-02119-y.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1858_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00792-2","volume":"14","author":"D Yang","year":"2021","unstructured":"Yang D, Wang Y, Zheng Y, Dai F, Liu S, Yuan M, et al. Silencing of LncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K\/AKT signaling pathway. J Ovarian Res. 2021;14(1):48. https:\/\/doi.org\/10.1186\/s13048-021-00792-2.","journal-title":"J Ovarian Res"},{"key":"1858_CR75","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.13241\/j.cnki.pmb.2024.08","volume":"24","author":"J Pan","year":"2024","unstructured":"Pan J, Rehanguli\u00b7KRB, Tusonggu\u00b7AME, Shen JJ, BO XL. The mechanism of LncRNA LUCAT1 regulating miR-375\/HMGB1 axis on insulin resistance in polycystic ovarian syndrome rats. Progress Mod Biomed. 2024;24:1439\u201343. https:\/\/doi.org\/10.13241\/j.cnki.pmb.2024.08.","journal-title":"Progress Mod Biomed"},{"key":"1858_CR76","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1016\/j.ygeno.2020.04.011","volume":"112","author":"HL Zhu","year":"2020","unstructured":"Zhu HL, Chen YQ, Zhang ZF. Downregulation of LncRNA ZFAS1 and upregulation of microRNA-129 repress endocrine disturbance, increase proliferation and inhibit apoptosis of ovarian granulosa cells in polycystic ovarian syndrome by downregulating HMGB1. Genomics. 2020;112:3597\u2013608. https:\/\/doi.org\/10.1016\/j.ygeno.2020.04.011.","journal-title":"Genomics"},{"key":"1858_CR77","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12734","volume":"26","author":"J Liu","year":"2022","unstructured":"Liu J, Zhao Y, Chen L, Li R, Ning Y, Zhu X. Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3\/miR-223\/GLUT4 and SNHG20\/miR-4486\/GLUT4 signaling. Mol Med Rep. 2022;26:218. https:\/\/doi.org\/10.3892\/mmr.2022.12734.","journal-title":"Mol Med Rep"},{"key":"1858_CR78","first-page":"227","volume":"31","author":"YJ Cui","year":"2022","unstructured":"Cui YJ, Zhang HM, Yan L, Wang Z, Zhang CX, Sui Q, et al. Expression of serum LncRNA MEG3 in patients with polycystic ovary syndrome and its relationship with insulin resistance. J Reprod Med. 2022;31:227\u201332.","journal-title":"J Reprod Med"},{"key":"1858_CR79","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.19829\/j.zgfybj.issn.1001-4411.2024.09.036","volume":"39","author":"HJ Zhang","year":"2024","unstructured":"Zhang HJ, Wu Y. Expression of maternal expression gene 3 of long Non coding RNA in patients with polycystic ovary syndrome and its correlation with prognosis. Maternal Child Health Care China. 2024;39:1689\u201392. 10.19829\/j. zgfybj.issn.1001-4411.2024.09.036.","journal-title":"Maternal Child Health Care China"},{"key":"1858_CR80","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3892\/mmr.2018.9793","volume":"19","author":"R Yang","year":"2019","unstructured":"Yang R, Chen J, Wang L, Deng A. LncRNA BANCR participates in polycystic ovary syndrome by promoting cell apoptosis. Mol Med Rep. 2019;19:1581\u20136. https:\/\/doi.org\/10.3892\/mmr.2018.9793.","journal-title":"Mol Med Rep"},{"key":"1858_CR81","doi-asserted-by":"publisher","unstructured":"Zhang YY. Expression and correlation of long non coding RNA MIRLET7BHG in different types of PCOS patients dissertation\/master\u2019s thesis. Dali: Dali University. 2022. https:\/\/doi.org\/10.27811\/d.cnki.gdixy.2022.000279","DOI":"10.27811\/d.cnki.gdixy.2022.000279"},{"key":"1858_CR82","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21:230\u201344. https:\/\/doi.org\/10.1038\/s41574-024-01057-w.","journal-title":"Nat Rev Endocrinol"},{"key":"1858_CR83","doi-asserted-by":"publisher","first-page":"118274","DOI":"10.1016\/j.jep.2024.118274","volume":"331","author":"HR Guan","year":"2024","unstructured":"Guan HR, Li B, Zhang ZH, Wu HS, Wang N, Chen XF, et al. Exploring the efficacy and mechanism of bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway. J Ethnopharmacol. 2024;331:118274. https:\/\/doi.org\/10.1016\/j.jep.2024.118274.","journal-title":"J Ethnopharmacol"},{"key":"1858_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123394","volume":"363","author":"LK Yang","year":"2025","unstructured":"Yang LK, Ma WJ, Wang X, Chen HR, Jiang YN, Sun H. Apoptosis in polycystic ovary syndrome: mechanisms and therapeutic implications. Life Sci. 2025;363:123394. https:\/\/doi.org\/10.1016\/j.lfs.2025.123394.","journal-title":"Life Sci"},{"key":"1858_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-025-01617-2","volume":"18","author":"D Liu","year":"2025","unstructured":"Liu D, Liu D, Zhou K. Polycystic ovary syndrome and epithelial-mesenchymal transition: Mendelian randomization and single-cell analysis insights. J Ovarian Res. 2025;18:33. https:\/\/doi.org\/10.1186\/s13048-025-01617-2.","journal-title":"J Ovarian Res"},{"key":"1858_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/nu16223916","volume":"16","author":"D Martinez Guevara","year":"2024","unstructured":"Martinez Guevara D, Vidal Ca\u00f1as S, Palacios I, G\u00f3mez A, Estrada M, Gallego J, et al. Effectiveness of probiotics, prebiotics, and synbiotics in managing insulin resistance and hormonal imbalance in women with polycystic ovary syndrome (PCOS): a systematic review of randomized clinical trials. Nutrients. 2024;16:3916. https:\/\/doi.org\/10.3390\/nu16223916.","journal-title":"Nutrients"},{"key":"1858_CR87","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-5044","volume":"9","author":"M Tu","year":"2021","unstructured":"Tu M, Wu Y, Mu L, Zhang D. Long non-coding rnas: novel players in the pathogenesis of polycystic ovary syndrome. Ann Transl Med. 2021;9:173. https:\/\/doi.org\/10.21037\/atm-20-5044.","journal-title":"Ann Transl Med"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01858-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01858-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01858-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:05:24Z","timestamp":1763507124000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01858-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1858"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01858-1","relation":{},"ISSN":["1757-2215"],"issn-type":[{"type":"electronic","value":"1757-2215"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}